Cite

HARVARD Citation

    El‐Adl, K. et al. (2020). 5‐(4‐Methoxybenzylidene)thiazolidine‐2, 4‐dione‐derived VEGFR‐2 inhibitors: Design, synthesis, molecular docking, and anticancer evaluations. Archiv der Pharmazie. 353 (9), p. n/a. [Online]. 
  
Back to record